- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06408987
Arthroscopically Assisted Versus Open Surgical Reduction of the Hip in Patients With Irreducible DDH Before the Walking Age
May 8, 2024 updated by: Mohamed Mahmoud Ebrahim Abd Allah, Assiut University
To determine the role of arthroscopy in treatment of the DDH.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
- The term developmental dysplasia of the hip (DDH) is composed of a spectrum of pathologies from stable acetabular dysplasia (femoral head centered in acetabulum but acetabulum is shallow) to concentric hips that are unstable (femoral head can be moved in and out of the confines of the acetabulum) and frankly dislocated hips in which there is a complete loss of contact between the femoral head and acetabulum.
- Open reduction , traditionally through a Smith - Peterson approach should be considered only if closed reduction cannot be performed.
- Medial open surgical reduction is a choice for the management of patients younger than 18 months with DDH. The minimal incision and minimal blood loss are advantages of this approach. Limited exposure of the hip joint is a disadvantage.
- The arthroscopic procedure was reported to represent a meaningful alternative to the open procedure due to a lower complication rate, a safe setting, a lower rate of residual dysplasia, no observed redislocation and low rate occurrence of osteonecrosis.
- All the intra-articular structures (hypertrophic ligamentum teres, transverse acetabular ligament, and pulvinar tissue) in the acetabulum that impede the reduction of the femoral head could be eliminated by using the arthroscopic technique.
Study Type
Interventional
Enrollment (Estimated)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: mohamed ebrahim, resident
- Phone Number: 01050707974
- Email: Mohamed.15259277@med.aun.edu.eg
Study Contact Backup
- Name: mohamed Abd El- Radi, dr
- Phone Number: 01225338766
- Email: mradi@aun.edu.eg
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
- Inclusion Criteria:
- Age: - from nine months to 18 months.
- Irreducible Hip Dislocation.
- Exclusion Criteria:
- Patient age: below 9 months or above 18 months.
- Teratologic hip dislocation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 1 .Arthroscopically assisted
Arthroscopically assisted in surgical reduction of the hip in patients with irreducible DDH before the walking age arm 1
|
Arthroscopically-Assisted reduction through anterolateral portal for visualization and other accessory portals for instrumentation to achieve reduction and postoperative immobilization in a hip spica.
Other Names:
|
Active Comparator: 2.open surgical reduction arm 2
open surgical reduction of the hip in patients with irreducible DDH before the walking age arm 2
|
Open reduction through a bikini incision anterior approach and postoperative immobilization in a hip spica.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Determination the success of reduction and incidence of redislocation rate
Time Frame: immediately postoperative
|
Documentation of concentric reduction of the hip in immediate postoperative MRI as an assessment tool for the success of the procedure.
|
immediately postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of the cosmetic appearance .
Time Frame: 3 month follow up
|
Documentation the wound size after 3 months follow up in clinical examination as an assessment tool of cosmotic appearance
|
3 month follow up
|
Assessment of the shortening
Time Frame: 1 year follow up
|
Assessment the incidence of leg length discrepancy and shortening that affect walking after one year follow up in clinical examination and x-ray as an assessment tool of shortening
|
1 year follow up
|
Assessment the incidence stiffness and decrease range of motion of the affected hip
Time Frame: 1 year follow up
|
documentation the range of motion of the affected hip and incidence of stiffness after 6 months follow up in clinical examination as an assessment tool of stiffness.
|
1 year follow up
|
Assessment the incidence of avascular necrosis in the affected hip
Time Frame: 1 year follow up
|
documentation the incidence of avascular necrosis of the affected head of hip after one year follow up in clinical examination and x-ray
|
1 year follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Nariman aboloyoun, Ass.Prof, Orthopedic and Trauma surgery at assiut university hospital
- Study Director: Hatem Galal El-Din Zaki, prof, Orthopedic and Trauma surgery at assiut university hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Roof AC, Jinguji TM, White KK. Musculoskeletal screening: developmental dysplasia of the hip. Pediatr Ann. 2013 Nov;42(11):229-35. doi: 10.3928/00904481-20131022-10.
- Jenner EA, Chauhan GS, Burahee A, Choudri J, Gardner A, Bache CE. Comparison of clinical and radiological outcomes for the anterior and medial approaches to open reduction in the treatment of bilateral developmental dysplasia of the hip: a systematic review protocol. Syst Rev. 2024 Feb 23;13(1):72. doi: 10.1186/s13643-023-02444-6.
- Duman S, Camurcu Y, Sofu H, Ucpunar H, Akbulut D, Yildirim T. Arthroscopic versus open, medial approach, surgical reduction for developmental dysplasia of the hip in patients under 18 months of age. Acta Orthop. 2019 Jun;90(3):292-296. doi: 10.1080/17453674.2019.1599775. Epub 2019 Apr 2.
- Presch C, Eberhardt O, Wirth T, Fernandez FF. Comparison of arthroscopic and open reduction of conservatively irreducible dislocated hips of children. J Child Orthop. 2019 Aug 1;13(4):377-384. doi: 10.1302/1863-2548.13.190057.
- Bulut O, Ozturk H, Tezeren G, Bulut S. Arthroscopic-assisted surgical treatment for developmental dislocation of the hip. Arthroscopy. 2005 May;21(5):574-9. doi: 10.1016/j.arthro.2005.01.004.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 15, 2024
Primary Completion (Estimated)
October 15, 2025
Study Completion (Estimated)
December 15, 2025
Study Registration Dates
First Submitted
April 15, 2024
First Submitted That Met QC Criteria
May 8, 2024
First Posted (Actual)
May 10, 2024
Study Record Updates
Last Update Posted (Actual)
May 10, 2024
Last Update Submitted That Met QC Criteria
May 8, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- hip arthroscopy in DDH
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Developmental Dysplasia of the Hip
-
Vestre VikenHF Kongsberg SykehusUnknownDevelopmental Dysplasia of the Hip (DDH)Norway
-
Second Affiliated Hospital of Wenzhou Medical UniversityBeijing Jishuitan HospitalCompletedDevelopmental Dysplasia of the Hip (DDH)China
-
Assiut UniversityCompleted
-
University of Colorado, DenverRecruiting
-
University of British ColumbiaNot yet recruitingHip Dysplasia | Developmental Dysplasia of the Hip | Hip Dysplasia, Congenital | Hip Dysplasia, DevelopmentalCanada
-
Assiut UniversityRecruitingDevelopmental Hip DysplasiaEgypt
-
University of British ColumbiaRecruitingHip Dislocation, Congenital | Congenital Hip Dysplasia | Congenital Dysplasia of the Hip | Congenital Hip Dislocation | Hip Dysplasia, Congenital, Nonsyndromic | Congenital Hip Displacement | Dislocation Of Hip, Congenital | Dislocation, Congenital Hip | Displacement, Congenital Hip | Dysplasia, Congenital... and other conditionsCanada
-
Hongwen XuTongji Hospital; Wuhan Union Hospital, China; Hunan Children's Hospital; Shenzhen... and other collaboratorsNot yet recruitingReduction | Developmental Dislocation of the Hip | Congenital Dislocation of Hip | Residual Deformity
-
University Hospital, BrestUnknownCongenital Hip DysplasiaFrance
-
Cairo UniversityRecruiting
Clinical Trials on arthroscopically assisted
-
Ostfold Hospital TrustVestre Viken Hospital Trust; Oslo University Hospital; Haukeland University HospitalRecruiting
-
Schulthess KlinikCompletedShoulder Injuries and DisordersSwitzerland
-
Daniel Collado-MateoAsociación Dame La PataRecruitingWork Related Stress | Occupational GroupsSpain
-
Daniel Collado-MateoPurina España (Reg. Trademark of Nestle S.A.)Enrolling by invitationEating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/BulimiaSpain
-
Daniel Collado-MateoAsociación de Padres de Personas Con Autismo (APNA); Asociación Nuevo Horizonte and other collaboratorsEnrolling by invitationAutism Spectrum Disorder | AutismSpain
-
Hospices Civils de LyonCompletedCritically Ill Adult Patients With Difficult WeaningFrance
-
Atlas UniversityNot yet recruitingDepression | Loneliness | Old Age; Debility | Nursing Home | Loss of Interest in Activities
-
Chang Gung Memorial HospitalRecruiting
-
St. Joseph's Healthcare HamiltonUnknown
-
Christina KruuseRecruitingTraumatic Brain Injury | Disorders of ConsciousnessDenmark